Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate

by Comstock, Timothy L., DeCory, Heleen H.
Published 2012

Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure

by Sheppard, John D., Comstock, Timothy L., Cavet, Megan E.
Published in Adv Ther (2016)

Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian...

by Sangwan, Virender S., Pearson, P. Andrew, Paul, Hemanth, Comstock, Timothy L.
Published in Ophthalmol Ther (2014)

An update on the surgical management of pterygium and the role of loteprednol etabonate ointment

by Sheppard, John D, Mansur, Arnulfo, Comstock, Timothy L, Hovanesian, John A
Published 2014

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis

by Comstock, Timothy L, Karpecki, Paul M, Morris, Timothy W, Zhang, Jin-Zhong
Published 2010

Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery

by Comstock, Timothy L, Paterno, Michael R, Singh, Angele, Erb, Tara, Davis, Elizabeth
Published 2011

Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant

by Sheppard, John D, Nguyen, Quan Dong, Usner, Dale W, Comstock, Timothy L
Published 2012

Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration

by Torkildsen, Gail, Proksch, Joel W, Shapiro, Aron, Lynch, Stephanie K, Comstock, Timothy L
Published 2010

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

by Silverstein, Bruce E, Morris, Timothy W, Gearinger, Lynne S, DeCory, Heleen H, Comstock, Timothy L
Published 2012

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

by Morris, Timothy W, Gearinger, Lynne S, Usner, Dale W, Paterno, Michael R, DeCory, Heleen H, Comstock, Timothy L, Haas, Wolfgang
Published 2011

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery

by Bucci, Frank A, Evans, Ruth E, Amico, Loretta M, Morris, Timothy W, Fluet, Angel T, Sanfilippo, Christine M, DeCory, Heleen H, Comstock, Timothy L
Published in Clin Ophthalmol (2015)